Cargando…
A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/ https://www.ncbi.nlm.nih.gov/pubmed/33617672 http://dx.doi.org/10.1002/ajh.26136 |
| _version_ | 1783717215895289856 |
|---|---|
| author | Daver, Naval Salhotra, Amandeep Brandwein, Joseph M. Podoltsev, Nikolai A. Pollyea, Daniel A. Jurcic, Joseph G. Assouline, Sarit Yee, Karen Li, Mengsong Pourmohamad, Tony Samineni, Divya Sumiyoshi, Teiko Vaze, Anjali Dere, Randall C. Ma, Connie Cooper, James |
| author_facet | Daver, Naval Salhotra, Amandeep Brandwein, Joseph M. Podoltsev, Nikolai A. Pollyea, Daniel A. Jurcic, Joseph G. Assouline, Sarit Yee, Karen Li, Mengsong Pourmohamad, Tony Samineni, Divya Sumiyoshi, Teiko Vaze, Anjali Dere, Randall C. Ma, Connie Cooper, James |
| author_sort | Daver, Naval |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8252033 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley & Sons, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82520332021-07-07 A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia Daver, Naval Salhotra, Amandeep Brandwein, Joseph M. Podoltsev, Nikolai A. Pollyea, Daniel A. Jurcic, Joseph G. Assouline, Sarit Yee, Karen Li, Mengsong Pourmohamad, Tony Samineni, Divya Sumiyoshi, Teiko Vaze, Anjali Dere, Randall C. Ma, Connie Cooper, James Am J Hematol Correspondences John Wiley & Sons, Inc. 2021-03-11 2021-05-01 /pmc/articles/PMC8252033/ /pubmed/33617672 http://dx.doi.org/10.1002/ajh.26136 Text en © 2021 The Authors. American Journal of Hematology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Correspondences Daver, Naval Salhotra, Amandeep Brandwein, Joseph M. Podoltsev, Nikolai A. Pollyea, Daniel A. Jurcic, Joseph G. Assouline, Sarit Yee, Karen Li, Mengsong Pourmohamad, Tony Samineni, Divya Sumiyoshi, Teiko Vaze, Anjali Dere, Randall C. Ma, Connie Cooper, James A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title | A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title_full | A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title_fullStr | A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title_full_unstemmed | A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title_short | A Phase I dose‐escalation study of DCLL9718S, an antibody‐drug conjugate targeting C‐type lectin‐like molecule‐1 (CLL‐1) in patients with acute myeloid leukemia |
| title_sort | phase i dose‐escalation study of dcll9718s, an antibody‐drug conjugate targeting c‐type lectin‐like molecule‐1 (cll‐1) in patients with acute myeloid leukemia |
| topic | Correspondences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252033/ https://www.ncbi.nlm.nih.gov/pubmed/33617672 http://dx.doi.org/10.1002/ajh.26136 |
| work_keys_str_mv | AT davernaval aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT salhotraamandeep aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT brandweinjosephm aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT podoltsevnikolaia aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT pollyeadaniela aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT jurcicjosephg aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT assoulinesarit aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT yeekaren aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT limengsong aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT pourmohamadtony aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT saminenidivya aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT sumiyoshiteiko aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT vazeanjali aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT dererandallc aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT maconnie aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT cooperjames aphaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT davernaval phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT salhotraamandeep phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT brandweinjosephm phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT podoltsevnikolaia phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT pollyeadaniela phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT jurcicjosephg phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT assoulinesarit phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT yeekaren phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT limengsong phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT pourmohamadtony phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT saminenidivya phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT sumiyoshiteiko phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT vazeanjali phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT dererandallc phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT maconnie phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia AT cooperjames phaseidoseescalationstudyofdcll9718sanantibodydrugconjugatetargetingctypelectinlikemolecule1cll1inpatientswithacutemyeloidleukemia |